The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OAB Treatment Market Research Report 2025
Synopsis
The global OAB Treatment market was valued at US$ 3852.1 million in 2023 and is anticipated to reach US$ 5489.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
AbbVie is the largest producer of OAB treatment worldwide, holding over 40% of the overall market share. North America is currently the largest consumption market in the world, with over 50% of the market, followed by Europe and Japan.
This report aims to provide a comprehensive presentation of the global market for OAB Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OAB Treatment.
Report Scope
The OAB Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OAB Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OAB Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma
Pfizer
Teva
Johnson & Johnson
Kyorin Pharmaceutical
Segment by Type
Anticholinergics
Mirabegron
Botox
Others
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OAB Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global OAB Treatment market was valued at US$ 3852.1 million in 2023 and is anticipated to reach US$ 5489.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
AbbVie is the largest producer of OAB treatment worldwide, holding over 40% of the overall market share. North America is currently the largest consumption market in the world, with over 50% of the market, followed by Europe and Japan.
This report aims to provide a comprehensive presentation of the global market for OAB Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OAB Treatment.
Report Scope
The OAB Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OAB Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OAB Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Astellas Pharma
Pfizer
Teva
Johnson & Johnson
Kyorin Pharmaceutical
Segment by Type
Anticholinergics
Mirabegron
Botox
Others
Segment by Application
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OAB Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OAB Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anticholinergics
1.2.3 Mirabegron
1.2.4 Botox
1.2.5 Others
1.3 Market by Application
1.3.1 Global OAB Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OAB Treatment Market Perspective (2019-2030)
2.2 OAB Treatment Growth Trends by Region
2.2.1 Global OAB Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 OAB Treatment Historic Market Size by Region (2019-2024)
2.2.3 OAB Treatment Forecasted Market Size by Region (2025-2030)
2.3 OAB Treatment Market Dynamics
2.3.1 OAB Treatment Industry Trends
2.3.2 OAB Treatment Market Drivers
2.3.3 OAB Treatment Market Challenges
2.3.4 OAB Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OAB Treatment Players by Revenue
3.1.1 Global Top OAB Treatment Players by Revenue (2019-2024)
3.1.2 Global OAB Treatment Revenue Market Share by Players (2019-2024)
3.2 Global OAB Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OAB Treatment Revenue
3.4 Global OAB Treatment Market Concentration Ratio
3.4.1 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OAB Treatment Revenue in 2023
3.5 OAB Treatment Key Players Head office and Area Served
3.6 Key Players OAB Treatment Product Solution and Service
3.7 Date of Enter into OAB Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OAB Treatment Breakdown Data by Type
4.1 Global OAB Treatment Historic Market Size by Type (2019-2024)
4.2 Global OAB Treatment Forecasted Market Size by Type (2025-2030)
5 OAB Treatment Breakdown Data by Application
5.1 Global OAB Treatment Historic Market Size by Application (2019-2024)
5.2 Global OAB Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America OAB Treatment Market Size (2019-2030)
6.2 North America OAB Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America OAB Treatment Market Size by Country (2019-2024)
6.4 North America OAB Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OAB Treatment Market Size (2019-2030)
7.2 Europe OAB Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe OAB Treatment Market Size by Country (2019-2024)
7.4 Europe OAB Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OAB Treatment Market Size (2019-2030)
8.2 Asia-Pacific OAB Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific OAB Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific OAB Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OAB Treatment Market Size (2019-2030)
9.2 Latin America OAB Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America OAB Treatment Market Size by Country (2019-2024)
9.4 Latin America OAB Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OAB Treatment Market Size (2019-2030)
10.2 Middle East & Africa OAB Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa OAB Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa OAB Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie OAB Treatment Introduction
11.1.4 AbbVie Revenue in OAB Treatment Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma OAB Treatment Introduction
11.2.4 Astellas Pharma Revenue in OAB Treatment Business (2019-2024)
11.2.5 Astellas Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OAB Treatment Introduction
11.3.4 Pfizer Revenue in OAB Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva OAB Treatment Introduction
11.4.4 Teva Revenue in OAB Treatment Business (2019-2024)
11.4.5 Teva Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson OAB Treatment Introduction
11.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
11.6 Kyorin Pharmaceutical
11.6.1 Kyorin Pharmaceutical Company Detail
11.6.2 Kyorin Pharmaceutical Business Overview
11.6.3 Kyorin Pharmaceutical OAB Treatment Introduction
11.6.4 Kyorin Pharmaceutical Revenue in OAB Treatment Business (2019-2024)
11.6.5 Kyorin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
